Medicine Walks Past the Smell Test

You lose your sense of smell and your brain is already telling you something — not metaphorically, but neurologically.

The research is clear. Olfactory dysfunction correlates with cognitive decline, with Parkinson's disease emerging years later and with the early stages of Alzheimer's when everything else still looks normal on an MRI. This is not speculation, not filed away as theoretical — it's documented and already happening to people you know.

Blood pressure checks happen at every primary care visit because we learned decades ago that measuring something simple could predict something catastrophic. A smell test takes ninety seconds, costs almost nothing, and could identify people five to ten years before symptoms emerge. When neuroplasticity still works, when early interventions might actually hold.

But smell testing remains experimental, something you do in a neurology clinic after you've already started forgetting things. Not before. Not when it matters. The olfactory nerve is the only direct contact your central nervous system has with the outside world. And when it fails, you're not just losing a luxury sense, you're watching the brain's front-line defense system collapse.

The barrier isn't scientific — it's institutional inertia wearing the face of caution. We would need to retrain primary care physicians, change billing codes, fund screenings for people who feel fine. Accept that early detection changes the entire game. That last part is the problem. We're better at managing disease than preventing it. Prevention requires commitment, and commitment requires believing you can change something before it breaks. The ability to smell trouble is not the same as smelling trouble. We have the first while choosing not to use it.